An elderly female with an acute episode of congestive heart failure, unaccompanied by any periods of hypotension, developed fulminant hepatic failure with an accompanying coagulopathy. Attempts to establish an etiology for her acute hepatic insufficiency, other than cardiac failure, proved negative. Fulminant hepatic failure as a consequence of congestive heart failure, without prolonged periods of hypotension preceding alteration in hepatic function, has not heretofore been described. Liver function is adversely effected in congestive heart failure. Hepatic ammonia clearance is impaired in cardiac failure and may be diminished to the point of resulting in hepatic encephalopathy. Coagulopathy is a frequent concomitant of fulminant hepatic failure. Establishing a clear etiology for a coagulopathy in the face of concomitant liver disease is difficult, thus making any therapeutic intervention fraught with peril.
Ammonia Liver Disease Congestive Heart Failure Liver Function Therapeutic Intervention
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Cooperman LB, Rubin IL: Toxicity of ethacrynic acid and furosemide. Am Heart J 85:831–834, 1973PubMedGoogle Scholar
Simmons F, Feldman B, Gerety D: Granulomatous hepatitis in a patient receiving allopurinal. Gastroenterology 62:101–104, 1972PubMedGoogle Scholar
Delage C, Lagace R: La peliose hepatique: Role etiologique possible des medicaments. Union Med Can 102:1888–1803, 1973PubMedGoogle Scholar
Eisenberg S, Madison L, Sensenbach W: Cerebral hemodynamic and metabolic studies in patients with congestive heart failure. Circulation 21:704–709, 1960PubMedGoogle Scholar
While TJ, Leevy DM, Brusca AM, et al.: The liver in congestive heart failure. Am Heart J 49:250–257, 1955PubMedGoogle Scholar
Rake MO, Flute PT, Pannell G, et al: Intravascular coagulation in acute hepatic necrosis. Lancet 1:533–537, 1970PubMedGoogle Scholar
Rake MO, Flute PT, Shilkin KB, et al: Early and intestive therapy of intravascular coagulation in acute liver failure. Lancet 2:1215–1218, 1971PubMedGoogle Scholar
Tan BH, Mori K, Richter D, et al: Study of the defibrination syndrome associated with acute hepatic failure. Surg Gynec Obstet 132:263–274, 1971PubMedGoogle Scholar
Roberts HR, Cedarbaum AI: The liver and blood coagulation: Physiology and pathology. Gastroenterology 63:297–320, 1972PubMedGoogle Scholar
Fletcher AP, Biederman O, Moore D, et al: Abnormal plasminogen-plasmin system activity (fibrinolysis) in patients with hepatic cirrhosis: Its cause and consequences. J Clin Invest 43:681–695, 1964PubMedGoogle Scholar
Deykin D: The role of the liver in serum induced hypercoagulability. J Clin Invest 45:256–263, 1966PubMedGoogle Scholar
Colman RW, Robboy SJ, Minna JD: Disseminated intravascular coagulation: An approach. Am J Med 52:679–689, 1972PubMedGoogle Scholar
Clark R, Rake MO, Flute PT, et al: Coagulation abnormalities in acute liver failure; pathogenetic and therapeutic implications. Scand J Gastroenterol 8 (Suppl. 19):63–70, 1973Google Scholar
Tucker JS, Woolf IL, Boyas BE, et al: Coagulation studies in acute hepatic failure. Gut 14:418, 1973Google Scholar
Gazzard BG, Clark R, Borirakchanyavat V, et al: A controlled trial of heparin therapy in the coagulation defect of Paracetamol induced hepatic necrosis. Gut 15:89–93, 1974PubMedGoogle Scholar
Hillenbrand P, Parbhoo SP, Jedrychowski A: Significance of intravascular coagulation and fibrinolysis in acute hepatic failure. Gut 15:83–88, 1974PubMedGoogle Scholar